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E1Astory of how the study of the DNA tumor viruses including polyoma, SV40 and
Adenovirus brought key insights into the structure and function of the Retinoblastoma protein (Rb).
Knudsen's model of the two-hit hypothesis to explain patterns of hereditary and sporadic retinoblastoma
provided the foundation for the tumor suppressor hypothesis that ultimately led to the cloning of the Rb
gene. The discovery that SV40 and Adenovirus could cause tumors when inoculated into animals was
startling not only because SV40 had contaminated the poliovirus vaccine and Adenovirus was a common
cause of viral induced pneumonia but also because they provided an opportunity to study the genetics and
biochemistry of cancer. Studies of mutant forms of these viruses led to the identiﬁcation of the E1A and Large
T antigen (LT) oncogenes and their small transforming elements including the Adenovirus Conserved Regions
(CR), the SV40 J domain and the LxCxE motif. The immunoprecipitation studies that initially revealed the size
and ultimately the identity of cellular proteins that could bind to these transforming elements were enabled
by the widespread development of highly speciﬁc monoclonal antibodies against E1A and LT. The
identiﬁcation of Rb as an E1A and LT interacting protein quickly led to the cloning of p107, p130, p300, CBP,
p400 and TRRAP and the concept that viral transformationwas due, at least in part, to the perturbation of the
function of normal cellular proteins. In addition, studies on the ability of E1A to transactivate the Adenovirus
E2 promoter led to the cloning of the heterodimeric E2F and DP transcription factor and recognition that Rb
repressed transcription of cellular genes required for cell cycle entry and progression. More recent studies
have revealed how E1A and LT combine the activity of Rb and the other cellular associated proteins to perturb
expression of many genes during viral infection and tumor formation.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe study of small DNA tumor viruses has provided key insights
into the structure and function of the Retinoblastoma protein Rb (RB1)
and the Rb related proteins p107 (RBL1) and p130 (RBL2). This
historical review highlights some of the key studies of Adenovirus,
SV40, polyoma and papilloma that helped to deﬁne the role of Rb in
tumor suppression. The ability of Adenovirus, SV40 and mouse
polyoma to induce tumors in a wide variety of in vivo and in vitro
transformation studies led to their intense study. The demonstration
that Adenovirus E1A, SV40 Large T antigen (LT) and Papillomavirus E7
could bind to and inactivate Rb, p107 and p130 provided a molecular
basis for the ability of these viruses to transform normal cells and
induce tumor formation. Signiﬁcantly, these small DNA viruses
continue to provide an important tool into revealing how the Rb
family contributes to tumor suppression, cell cycle control, gene
expression, and differentiation (Fig. 1).er Institute, USA.
l rights reserved.Retinoblastoma
The important studies of Knudsen on hereditary patterns for
childhood retinoblastoma created the foundation for the tumor
suppressor hypothesis. He observed that there was a higher likelihood
of developing multiple retinoblastoma tumors in one or both eyes in
children at a younger age if there was a family history of
retinoblastoma. In contrast, children without a family history were
more likely to present with a single tumor at an older age. Knudsen
applied a statistical analysis to these observations regarding age of
onset and tumor number and concluded that the most likely
explanation for the development of retinoblastoma involved a two-
hit hypothesis with two independent mutation events (Knudson,
1971). In the case of hereditary retinoblastoma, the child inherited a
mutated gene and acquired a second mutation in a somatic cell. In
contrast, sporadic retinoblastoma developed when two independent
mutations occurred in the same somatic cell. It was proposed later
that the two mutations occurred in the two alleles of the same gene
(Comings, 1973; Godbout et al., 1983).
Genetic linkage studies of chromosomal abnormalities in heredi-
tary retinoblastoma focused on chromosome 13q14 near the Esterase
Fig. 1. Models for the effect of SV40 Large T antigen and Adenovirus E1A on Rb. (A) Rb binding to the heterodimeric transcription factor E2F/DP represses transcription. (B)
Phosphorylation of Rb reduces binding to E2F/DP releasing Rb from the promoter and permitting activation of E2F. (C) SV40 LT or Ad E1A binding to Rb removes it from E2F/DP. (D)
SV40 LT recruits p300/CBP in a p53-dependent manner to Rb and turns the repressed complex into an activating complex. (E) Ad E1A brings p300/CBP to Rb-bound promoters to
promote histone acetylation and increased gene expression. (F) Ad E1A recruits Rb to p300/CBP bound to transcription factors turning an active promoter to a repressed promoter.
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evidence for loss-of-heterozygosity and supported the idea that
retinoblastoma was a recessive cancer where the abnormal chromo-
some was inherited and the corresponding wild type chromosomal
segment was lost in tumor cells (Benedict et al., 1983; Cavenee et al.,
1983, 1985; Godbout et al., 1983; Sparkes et al., 1983). The cloning of
the retinoblastoma cDNA led to the determination that it encoded a
110 kDa nuclear phosphorylated protein (Friend et al., 1986; Lalande
et al., 1984; Lee et al., 1987a, 1987b). Several additional studies
demonstrated that the Rb1 gene isolated from retinoblastoma tumors
contained intragenic mutations with premature stop codons, in-
frame deletions, and point substitutions conﬁrming the model that
mutation resulted in loss of function (Friend et al., 1987; Fung et al.,
1987; Horowitz et al., 1989; Kaye et al., 1990; Lee et al., 1987a; Shew
et al., 1990).
Viral induced retinoblastoma
The study of small DNA tumor viruses began with the observation
that they could reproducibly cause tumor formation in a variety of
animals. The early studies of Stewart and Eddy demonstrated that
polyoma virus produced in cell culture induced tumors when
inoculated into newborn hamsters provided a framework to deter-
mine if other viruses could do the same (Eddy et al., 1958; Stewart et
al., 1957). Soon afterwards, it was recognized that polyoma virus could
convert or transform normal rodent cells in vitro to acquire features of
cells derived from polyoma induced tumors including growth in
nutrient-poor conditions, growth above a monolayer and formation of
tumors when implanted as xenografts (Sachs and Winocour, 1959;
Vogt and Dulbecco, 1960). These studies led to the observation that
SV40, a virus that contaminated rhesus monkey kidney cells used to
prepare the polio vaccine, could also cause tumors in newborn
hamsters and transform normal cells (Eddy et al., 1961, 1962; Rabson
and Kirschstein, 1962; Sweet and Hilleman, 1960; Todaro and Green,
1964). Similarly, human adenoviruses formed tumors when injected
into newborn hamsters (Huebner et al., 1962; Trentin et al., 1962). The
disturbing observations that the life-saving polio vaccine was
contaminated with SV40 and the common human respiratory virus
Adenovirus could cause tumors in animals captured the public and
scientiﬁc interests. These important studies led to the search forviruses in human tumors and the investigation into the speciﬁc
mechanisms that enabled these viruses to cause tumors in experi-
mental model systems.
The type of tumor that developed in an animal upon viral
inoculation often depended on the site of injection. In a series of
experiments, Mukai and colleagues observed that injection of
Adenovirus 12 directly into the vitreous of newborn rats (Kobayashi
and Mukai, 1973), mice (Mukai et al., 1977), and baboons (Mukai et al.,
1980) led to the development of tumors that were classiﬁed as
retinoblastomas by histological and electron microscopy methods. In
each study, approximately 10% of the virus-treated animals developed
retinoblastomas with evidence that the tumors expressed adenovirus
gene products by immunostaining (Kobayashi et al., 1982). These and
other reports prompted several studies to search for the presence of
viruses in human retinoblastoma. However, no evidence for adeno-
virus or JC polyomavirus was reported in several human retinoblas-
tomas (Howard et al., 1992; Mak et al., 1982; Ueno et al., 1987; Zu
Rhein, 1983). In contrast, the presence of HPV in cervical cancer and
the newly described Merkel Cell Polyoma virus in Merkel cell
carcinoma are two examples of DNA viruses whose genomes are
found to be integrated into the chromosomes of human tumors (Durst
et al., 1983; Feng et al., 2008).
Adenovirus E1A and SV40 LT
The ability of Adenovirus, SV40 and mouse polyoma to induce
tumors in vivo and transform cells in vitro led to studies that can be
broadly grouped into genetics and biochemistry. The genetic studies
focused on identifying the viral genes and eventually the speciﬁc
residues within the viral oncogenes that were required for transfor-
mation. The biochemistry studies focused on the speciﬁc interaction of
the viral oncogenes with the cellular host proteins and the functional
consequences of those interactions.
The relatively small size of the viral genomes enabled the
development of mutant viruses to map their transforming genes.
Initially, generation of temperature sensitivemutants of SV40mapped
the transforming function to the A or T (tumor) antigen gene (Brugge
and Butel, 1975; Kimura and Itagaki, 1975; Martin and Chou, 1975;
Osborn and Weber, 1975; Tegtmeyer, 1975). In addition, generation of
stable cell lines led to the conclusion that the early genes of SV40 and
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the transformed phenotype (Abrahams et al., 1975; Flint et al., 1975).
The tumor antigens fromAdenovirus, SV40 and polyomawere initially
detected with sera tumor-bearing animals. This gave way to the use of
speciﬁc sera from generated from rabbits immunized with peptides or
recombinant protein corresponding to the early gene products and
eventually to monoclonal antibodies against the viral oncoproteins
(Crawford and Harlow, 1982; Harlow et al., 1985; Lassam et al., 1979).
The widespread development of monoclonal antibodies provided the
high speciﬁcity for viral proteins that enabled identiﬁcation of co-
immunoprecipitated cellular proteins. The intersection of these
genetic and biochemical studies led to the recognition that the
binding of the viral transforming oncogenes to speciﬁc cellular
proteins was dependent on small transforming domains within the
viral oncogenes.
Genetic studies of SV40 LT and Adeno E1A transformation
In attempts to understand the mechanisms for cellular transfor-
mation and tumorigenesis, mutants of adenovirus, polyoma and SV40
viruses were generated. These mutant viruses were scored for their
ability to induce tumors in vivo and transform cell lines in vitro.
Genetic studies of SV40 LT were complicated by ability of LT to
perform so many unique functions. These functions included ATPase,
helicase, DNA binding including origin speciﬁc binding, immortaliza-
tion and cellular transformation. Early studies demonstrated that each
of these functions were dependent on LT (A gene). Various strategies
to develop mutants enabled dissection of each of these functions
including the requirement for LT antigen for cellular transformation.
Keith Peden and Jim Pipas generated a large number of LT mutants
that were used to deﬁne several functional domains within LT (Peden
et al., 1980). Kalderon and Smith generated small in frame deletions
and point substitutions within SV40 LT that were characterized for
viral replication and transformation of Rat-1 cells (Kalderon and
Smith, 1984). They described a LT mutant K1 that contained a single
point substitution at residue 107 (E107K). K1was completely defective
for transformation yet retained the ability to promote viral replication
(Kalderon and Smith, 1984). Chen and Paucha extended these studies
to demonstrate that LT residues 106 to 114 were required for
transformation of rat and mouse cells (Chen and Paucha, 1990).
Several groups focused both on the ability of Adenovirus to
stimulate transcription of adenoviral and cellular genes as well as to
transform cells. It was recognized that E1A could stimulate cellular
DNA synthesis and cellular transformation (Braithwaite et al., 1983;
Haley et al., 1984; Kaczmarek et al., 1986; Montell et al., 1984). It was
also recognized that the E1A products from a variety of human and
simian adenoviruses shared highly conserved regions of homology
(Kimelman et al., 1985; van Ormondt et al., 1980). Conserved Regions 1
(CR1), CR2 and CR4 are present in both 12S and 13S forms of E1A,
while CR3 is unique to 13S (Berk, 2005).
The large Adenovirus 13S E1A product contained a unique domain
that was required for transcriptional transactivation (Lillie et al.,
1986, 1987; Moran et al., 1986a). The smaller 12S E1A product was
required for transformation (Lillie et al., 1986; Moran et al., 1986b).
Mutations within the 12S product rendered the mutant constructs
within the CR1 and CR2 defective in transformation and induction of
cellular DNA synthesis assays (Kimelman, 1986; Kimelman et al.,
1985; Lillie et al., 1987). It was also recognized that the 12S E1A could
repress transcription from a variety of promoters and that this
activity could be separated from its transforming activity (Lillie et al.,
1986; Smith and Ziff, 1988; Stein and Ziff, 1987; Velcich et al., 1986;
Velcich and Ziff, 1988).
Betty Moran and colleagues generated cDNAs for the 12S and 13S
E1A genes and generated a series of mutations. Expression of E1A 12S
constructs with mutations within residues 80 to 120 did not affect the
transforming activity but mutations within residues 121 to 150,corresponding to CR2 rendered the 12S construct transformation
defective. In particular they noted that the point substitution mutant
C124G was transformation defective (Moran et al., 1986b). Moran
demonstrated that substitution of the transforming region of SV40LT
for CR2 of E1A restored the E1A transforming activities implying that
these two viral oncoproteins used similar processes (Moran, 1988).
Figge et al. also noted the similarity between this region of SV40 LT
with CR2 of E1A (Figge et al., 1988). It was noted that the residues
LxCxE were highly conserved among the Adenovirus E1A CR2
domains and were present in many serotypes of HPV E7 proteins
and LT from a variety of polyoma viruses (Dyson et al., 1989b, 1990;
Munger et al., 1989; Stabel et al., 1985; Vousden and Jat, 1989).
Identiﬁcation of LT and E1A associated proteins
The observation that viral gene products could bind speciﬁcally to
cellular proteins provided an important insight into their ability to
transform cells. Several studies were signiﬁcant in pointing the way to
discovery of the interaction of E1A and LT with Rb. The identiﬁcation
of p53 as a cellular protein that could bind to SV40 LT was enabled by
the generation of increasingly speciﬁc antibodies against LT (Lane and
Robbins, 1978; Linzer and Levine, 1979; Smith et al., 1979b). The
observation that the viral oncoproteins interacted directly with the
host cellular environment led to the model that transformation by a
viral oncogene might occur by the perturbation of an existing cellular
protein addition and not necessarily by the addition of a new function.
Although the early studies of p53 did not distinguish between thewild
type and dominant negative functions of mutant p53, it was
appreciated that p53 was linked to immortalization function of LT
(Jenkins et al., 1984; Lane, 1984). It was not until 10 years later when it
was recognized that p53 functioned as a tumor suppressor and that LT
and Ad E1B served to inactivate wild type p53 function (Finlay, Hinds,
and Levine, 1989; Kierstead and Tevethia, 1993; Yew and Berk, 1992;
Zhu et al., 1991).
The study of the DNA tumor viral interactions with cellular
proteins was also inspired by the report that polyoma middle T
antigen (MT) was associated with tyrosine kinase activity (Eckhart et
al., 1979; Schaffhausen and Benjamin, 1979; Smith et al., 1979a). This
observation led to the discovery that MT bound to the Src tyrosine
kinase (Courtneidge and Smith, 1983). Similarly, MT associationwith a
phospho-inositol kinase activity led to the identiﬁcation of the PI3
kinase (Kaplan et al., 1987; Whitman et al., 1985). Here, MT
transforming activity was correlated with acquisition of two different
kinase activities and with a gain of function present in the MT protein
complex. Given the identiﬁcation of p53, Src and PI3K as speciﬁc
associated cellular proteins , many labs were emboldened to search for
additional binding proteins of transforming viral oncoproteins.
Several groups pursued identiﬁcation of cellular proteins that
could bind to E1A proteins. Branton and colleagues developed a
series of anti-peptide antisera that could immunoprecipitate E1A and
observed co-precipitation of several phosphorylated proteins includ-
ing a doublet of approximately 105 kDa and another protein larger
than 250 kDa (Rowe et al., 1983; Yee and Branton, 1985). Signiﬁcantly
these cellular proteins could be afﬁnity puriﬁed using E1A produced
in bacteria indicating that these proteins pre-existed in the cell prior
to E1A expression and were not dependent on expression of any
other viral genes (Egan et al., 1987). Further studies indicated that
residues 111–127 within CR2 of E1A as well as residues 30–60 within
CR1 were required for binding to the 105 and 107 kDa proteins (Egan
et al., 1988).
Harlow et al. observed that monoclonal antibodies against
Adenovirus E1A could co-precipitate a large number of cellular
proteins (Harlow et al., 1986). The size of these cellular proteins
ranged from 28 to 300 kDa including species of 110 and 130 kDa.
Furthermore, they observed that these cellular proteins could be co-
precipitated with E1A from cell lines with stable E1A expression such
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transiently transfected with plasmids expressing a cDNA for Ad5 12S
or 13S E1A.
E1A and LT bind to Rb
The key breakthrough came immediately after the publication that
demonstrated Rb protein was a nuclear 110 kDa phosphoprotein (Lee
et al., 1987b). PeterWhyte and Karen Buchkovich, postdoctoral fellows
with Ed Harlow, recognized that the reported gel migration pattern of
the Rb protein made it a candidate for the 105 kDa E1A-associated
protein that they had been pursuing (Harlow et al., 1986; Lee et al.,
1987b;Whyte et al., 1988). They had generated amonoclonal antibody
C36 that recognized a 105 kDa protein by immunizing mice with
immunoprecipitates of E1A from 293 cells. Using this antibody and in
collaboration with Robert Weinberg's laboratory, they conﬁrmed that
Rb was the 105 kDa cellular protein speciﬁcally associated with E1A
and reported it as the ﬁrst demonstration of a physical link between
an oncogene and an anti-oncogene.
Immediately following this report, David Livingston et al., in
collaboration with Wen-Hwa Lee, reported that SV40 LT could also
bind speciﬁcally to Rb (DeCaprio et al., 1988). Signiﬁcantly, they
observed that several LT mutants that were defective in transforma-
tionwere unable to bind to Rb. These LT mutants including K1 (E107K)
disrupted the highly conserved sequence LxCxE present in E1A as
polyoma LT (Kalderon and Smith, 1984). The Harlow and Livingston
reports ﬁrmly linked the transforming ability of viral oncoproteins
E1A and LT to binding to Rb. These two reports were followed by the
observation that HPV E7 proteins as well as the LT from several
different polyoma viruses could also bind to Rb (Dyson et al., 1989b,
1990; Munger et al., 1989). A transgenic mouse that developed
retinoblastoma expressed SV40 LT driven by the luteinizing hormone
β (Lhb) (Windle et al., 1990). Signiﬁcantly, the group demonstrated
that LT could co-precipitate Rb from lysates prepared from tumor cells
supporting the hypothesis that retinoblastoma developed by the
functional inactivation of the Rb protein by LT.
The next signiﬁcant insight into Rb function followed when it was
recognized that the Rb protein underwent phosphorylation in a cell
cycle dependent manner. In the G0 state of quiescent or differ-
entiated cells and the G1 phase of cycling cells, the Rb protein was
relatively hypo- or under-phosphorylated. As cells entered into S
phase, Rb underwent a series of phosphorylation modiﬁcations
(Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989;
Mihara et al., 1989). Phosphorylation of Rb was also decreased in cells
undergoing differentiation (Mihara et al., 1989), TGF-β treatment
(Laiho et al., 1990; Pietenpol et al., 1990), and senescence (Stein et al.,
1990a). It was also recognized that mutant forms of Rb failed to
become phosphorylated or bind to the viral oncoproteins (Bignon et
al., 1990; Kaye et al., 1990; Templeton et al., 1991). While the cell
cycle dependent phosphorylation appeared dramatic in western blots
for wild type Rb, its functional signiﬁcance was not immediately
apparent.
Livingston and colleagues recognized that SV40 LT could prefer-
entially bind to the under-phosphorylated or G0/G1 form and not to
the hyper-phosphorylated or S/G2 forms of Rb (Ludlow et al., 1989,
1990). This observation implied that transformation by LT was linked
to its ability to bind to the under-phosphorylated form of Rb during
the G1 phase of the cell cycle and suggested that the G1 form of Rb
served a growth suppressing function that the LT transforming
function could overcome. It was then reported that overexpression
of Rb could inhibit progression of the cell from G1 phase to S phase of
the cell cycle (Goodrich et al., 1991). Similarly growth suppression by
TGF-β was mediated by the decrease in Rb phosphorylation (Laiho et
al., 1990; Pietenpol et al., 1990). These results suggested that loss of the
G1 growth suppressor function of Rb could be achieved in three
different ways; phosphorylation of the normal Rb protein, inactivationby mutation of the Rb gene, or speciﬁc binding to one of the viral
oncoproteins.
Notably, these observations occurred during the exciting time
when the Cyclin B/Cdc2 kinase was demonstrated to be required for
entry into mitosis in mammalian cells (Draetta and Beach, 1988;
Draetta et al., 1987,1989; Lee and Nurse, 1987; Pines and Hunter, 1989;
Riabowol et al., 1989). These discoveries led to the search for
additional substrates of the Cdc2 kinase. It was observed that Rb
could be directly phosphorylated by the mitosis speciﬁc kinase in vitro
(Taya et al., 1989) and that Cdc2 could phosphorylate LT and promotes
SV40 viral replication (McVey et al., 1989). Later it was appreciated
that there was a sequential appearance of activity of several CDK-
dependent kinases including Cyclin D/Cdk4, Cyclin E/Cdk2, Cyclin A/
Cdk2 and Cyclin B/Cdc2 and that Rb could be sequentially phosphory-
lated as it progressed through the cell cycle (DeCaprio et al., 1992;
Hinds et al., 1992; Lees et al., 1991).
E1A and LT bind to p107 and p130
Given the identiﬁcation of Rb as an associated protein for E1A and
LT, many laboratories sought to identify additional cellular proteins
that could bind to the transforming domains of E1A and LT. It was
quickly recognized that E1A and LT binding to p107was dependent on
the same LxCxE residues required for binding to Rb (Dyson et al.,
1989a; Ewen et al., 1989). This led to its cloning by mass spectroscopic
identiﬁcation of peptides from a preparative scale immunoprecipita-
tion for LT (Ewen et al., 1991). It was observed that Adenovirus E1A
was bound and phosphorylated by Cyclin A/Cdc2 and Cyclin A/Cdk2
(Dumont and Branton, 1992; Giordano et al., 1989; Herrmann et al.,
1991; Kleinberger and Shenk, 1991; Tsai et al., 1991). E1A binding to
Cyclin Awas probably mediated by p107 since it was shown that p107
could bind directly to Cyclin A/Cdk2 independently of the viral
oncogenes (Ewen et al., 1992; Faha et al., 1992).
Three laboratories used different techniques to identify p130, the
third Rb family member. Mayol et al. cloned the cDNA by degenerate
PCR ampliﬁcation based on nucleotide sequence homology between
RB1 and RBL1 (Mayol et al., 1993). Greg Hannon cloned p130 by a
yeast-2-hybrid screen using Cdk2 as bait and demonstrated the
speciﬁc binding of p130 to E1A (Hannon et al., 1993). Peter Whyte
cloned the cDNA by performing a large-scale immunoprecipitation of
E1A followed by mass spectroscopic identiﬁcation of co-precipitated
proteins (Li et al., 1993). The p107 and p130 proteins also exhibited
features of cell cycle regulators. Weinberg et al. observed the strong
preference for E1A binding to p130 during G0 and early G1 while
p107 became the major associated E1A species during S phase
(Cobrinik et al., 1993).
E1A and LT bind to p300, CBP, p400 and TRRAP
The genetic analysis of E1A revealed that certain residues in the N-
terminus were required to induce cellular DNA synthesis and
transformation that disrupted binding to a 300 kDa protein but did
not affect binding to Rb (Howe et al., 1990). Several labs identiﬁed an
E1A-associated 300 kDa protein (Egan et al., 1988; Harlow et al., 1986;
Yee and Branton,1985). Certain point substitutions and small in-frame
deletions in CR1 disrupted binding to p300 (Stein et al., 1990b; Wang
et al., 1993). These observations led to the cloning of p300 (EP400) in a
preparative scale immunoprecipitation for E1A (Eckner et al., 1994). It
was quickly recognized that p300 was highly homologous to CBP
(CREB binding protein or CREBBP) that served as a co-activator for
CREB and both contained histone acetyl transferase (HAT) activity
(Arany et al., 1994; Chrivia et al., 1993; Kwok et al., 1994; Ogryzko et al.,
1996). E1A binding to CBP and p300 could occur independently of its
association with Rb and the ability of 12S E1A to serve as
transcriptional repressor was linked to binding to p300 and CBP
(Chakravarti et al., 1999; Hamamori et al., 1999). It was also reported
278 Minireviewthat p300/CBP could acetylate E1A on lysine residue K239 that results
in disruption of binding to CtBP (Zhang et al., 2000).
The question of whether LT could also bind to p300 and CBP was
raised when it observed that LT could complement the transforming
ability of a p300-binding mutant E1A in a ras foci formation assay
(Yaciuk et al., 1991). This was followed by the demonstration that LT
could also bind to CBP and p300 (Eckner et al., 1996). While it
appeared that E1A could bind directly to p300/CBP, LT bound to p300/
CBP in a p53-dependent manner (Borger and DeCaprio, 2006; Lill et
al., 1997a). CBP binding to LT also serves to speciﬁcally acetylate LT and
may affect the stability of LT (Poulin et al., 2004; Shimazu et al., 2006).
HPV E7 has also been shown to bind to p300 (Bernat et al., 2003).
Therefore, the viral oncogenes have served to intricately link p300,
CBP, Rb and the Rb-like proteins to their ability to transform cells.
In addition to p300 and CBP, E1A and LT have been shown to
several additional cellular proteins. Branton et al. ﬁrst described the
association with p400 and identiﬁed E1A mutants that could bind to
p300, CBP, and Rb but failed to bind to p400 (Barbeau et al., 1994).
Livingston and colleagues determined that LT could also bind to p400
and cloned it by purifying the protein from an E1A immunoprecipita-
tion (Fuchs et al., 2001; Lill et al., 1997b). The E1A associated protein
p400 was also shown to bind to TRRAP (transformation/transcription
domain-associated protein) known to be involved in myc activation
and the interaction is required for E1A-mediated transformation
(Deleu et al., 2001; Lang and Hearing, 2003; McMahon et al., 1998).
The E1A interaction with p400 and TRRAP has been shown to be
important in a number of processes including promoting apoptosis,
suppressing senescence, as well as activation of a variety of
transcription factors including myc (Chan et al., 2005; Drdova and
Vachtenheim, 2004; Samuelson et al., 2005; Tworkowski et al., 2008;
Young et al., 2008).
Rb associated proteins
Having determined that LT and E1A bind speciﬁcally to Rb, several
laboratories mapped the domains within Rb required for binding to
E1A and LT. While the N-terminal 390 residues of Rb were largely
dispensable for this function, the C-terminal two thirds of Rb could
bind efﬁciently to LT and E1A. This fragment was referred to as the
large pocket domain of Rb and central domain that was mapped to
residues 379 to 792 and referred to as small pocket (Hu et al., 1990;
Huang et al., 1990; Kaelin et al., 1990). Interestingly this central
domain was frequently the site of point mutations and other
inactivating mutations in Rb1 derived from retinoblastomas and
other tumors. Conversely, it was recognized that many mutant forms
of Rb derived from tumors failed to bind to LTor E1A correlating loss of
bindingwith loss of function (Hu et al., 1990; Huang et al., 1990; Kaelin
et al., 1990; Pietenpol et al., 1990). For example, a single point
substitution C706F mutation derived from a retinoblastoma resulted
in loss of binding to SV40 T antigen (Bignon et al., 1990). These studies
implied that the viral oncogenes disrupted the normal function of Rb
that was essential for tumor suppression.
This model led to the search for cellular proteins that could
compete with LT and E1A for binding to the large and small pocket of
Rb. While there have been more than 100 cellular proteins identiﬁed
as interacting with Rb, some of the factors identiﬁed early have been
themost highly validated. Manymore Rb-associated factors have been
reported although their signiﬁcance is not well understood (Morris
and Dyson, 2001). The very ﬁrst Rb-associated proteins identiﬁed
were RBP1 (ARID4A) and RBP2 (JARID1A) have continued to be studied
in the context of Rb (Defeo-Jones et al., 1991; Fattaey et al., 1993;
Kaelin et al., 1991; Klose et al., 2007; Lai et al., 1999; Nagl et al., 2007).
RbAp46 (RBBP7) and RbAp48 (RBBP4) were shown to competewith LT
for binding to Rb (Huang et al., 1991; Qian et al., 1993). These two
WD40-containing proteins have been shown to be in histone
modifying complexes with Rb homologues in plant, worm and ﬂy(Ach et al., 1997; Lu and Horvitz, 1998; Murzina et al., 2008; Taylor-
Harding et al., 2004). In mammalian cells, RBBP4 is a speciﬁc member
of the p130 associated DREAM complex (Litovchick et al., 2007).
The most highly validated Rb associated factor, E2F, was originally
identiﬁed as a cellular factor that served to activate Adenoviral gene
transcription. Joe Nevins and colleagues had determined that E1A
serves to relieve the effects of a cellular factor that represses
adenovirus promoters including the E2 promoter resulting in delayed
and inefﬁcient viral gene production (Imperiale et al., 1983; Nevins,
1981). Using an electrophoretic mobility shift assay (EMSA) they
identiﬁed a cellular DNA binding factor that bound to the Adenovirus
E2 promoter and determined using an in vivo DNA footprinting assay
that binding was increased in the presence of E1A (Kovesdi et al.,
1986b). Furthermore, this activity was present in the absence of E1A
when the promoter was active (Kovesdi et al., 1986a). Notably, the E2
promoter contained a 16 bp element repeat in opposite orientations
that was activated by E1A in cooperation with the Adenovirus E4 ORF
6/7 19 kDa product (Neill et al., 1990; Reichel et al., 1989; Yee et al.,
1987).
A signiﬁcant breakthrough came it was recognized that E1A could
dissociate E2F from a cellular factor. Strikingly, this activity was
dependent on CR2 of E1A and the implication that this cellular factor
could be related to Rb was recognized immediately (Bagchi et al.,
1990). In addition they found CR1 and CR2 was required for E1A
dissociation of Rb (Raychaudhuri et al., 1991). Nevins and colleagues
reported that the under/hypo-phosphorylated from of Rb could bind
to E2F and that E1A as well as LT and E7 could dissociate Rb from E2F
(Chellappan et al., 1992; Chellappan et al., 1991). It was also observed
that HPV E7 could transactivate E2 promoter in a manner similar to
E1A (Phelps et al., 1991).
Using GST-Rb (large pocket) mixed with cellular lysates, Livingston
and colleagues asked if PCR ampliﬁcation of degenerate DNA
oligonucleotides could enrich for speciﬁc DNA sequences. Remarkably
they identiﬁed several sequences that corresponded to the E2F
binding sites identiﬁed in the E2 promoter (Chittenden et al., 1991).
E2F1 was also cloned using recombinant Rb to screen a lambda phage
expression library (Helin et al., 1992; Kaelin et al., 1992). While Rb
binding correlatedwith repression of E2F activity (Hiebert et al., 1992),
overexpression of E2F1 could promote entry into S phase in a manner
similar to Adeno E1A (Johnson et al., 1993).
Independently, La Thangue and Rigby used in vitro transcription
and electrophoretic mobility shift assays (EMSA) to identify a cellular
factor that could complement the ability of E1A to transactivate the E2
promoter (La Thangue and Rigby, 1987). They observed that this
activity was negatively regulated during differentiation and referred
to it as the differentiation-regulated transcription factor (DTRF) (La
Thangue et al., 1990). Signiﬁcantly, they observed that a DTRF-
containing complex that was enriched upon differentiation could be
disrupted by addition of in vitro translated E1A in a CR1 and CR2
dependent manner (Bandara and La Thangue, 1991). Given the
dependence on CR1 and CR2 domains of E1A, they asked if this
complex contained Rb and observed that this complex could be
supershifted with two different Rb monoclonal antibodies. They
puriﬁed and cloned the cDNA for the DRTF-polypeptide-1 (DP1) using
a DNA afﬁnity column with sequences from the Adenovirus E2
promoter (Bandara et al., 1991; Girling et al., 1993). They demon-
strated that DP1 formed a heterodimeric complex with E2F1 and
cooperated to bind to the E2 promoter and to Rb, p107 and the Adeno
E4 ORF 6/7 19 kDa protein (Bandara et al., 1993, 1994; Helin et al.,
1993; Huang and Hearing, 1989). The E4 ORF 6/7 protein bound to a
highly conserved motif within E2F1 deﬁned as the marked box (Helin
and Harlow, 1994; Jost et al., 1996).
The E2 promoter assays implied that E1A served as a cellular E1A
activity that could promote gene expression. The EMSA assays
conﬁrmed that E1A could serve to dissociate Rb from E2F activity.
Similarly using Rb afﬁnity columns it was also clear that E1A, LT and
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assays provided the methods to deﬁne the domains within the viral
oncoproteins required to dissociate Rb from E2F. The LxCxE motif
clearly played an important role in the high afﬁnity binding of the viral
oncoproteins to Rb. A minimal peptide of 9 residues corresponding to
the LxCxE motif of HPV16 E7 could compete with Rb binding to E2F
and to DNA (Jones et al., 1992, 1990). Dyson et al. noted that the
peptides corresponding to CR1 of E1A could also make a distinct
contact with Rb that could not be competed with peptides from CR2
(Dyson et al., 1992). This led to the recognition that the E1A CR1
peptide could compete directly with the C-terminal domain of E2F for
Rb binding. Since the original cloning of E2F1 and DP1, there has been
the identiﬁcation of a large family of E2F and DPmolecules that serve a
variety of roles in cell cycle and other biological processes (van den
Heuvel and Dyson, 2008).
The crystal structure of Rb provided signiﬁcant insight into how
viral proteins interacted with the Rb small pocket. It was noted that
the A and B domains of small pocket each contained ﬁve alpha helices
and formed two cyclin domains (Kim and Cho, 1997; Lee et al., 1998).
The A and B domains were bound tightly to each other with a large
area of highly conserved residues located in the fold between the A
and B domains. The LxCxEmotif of HPV E7 bound to a surface exposed
cleft contained within the B domain (Lee et al., 1998). Notably, the side
chains of leucine, cysteine and glutamate in the LxCxE binding motif
made direct contact to Rb while the x-residues were oriented away
from Rb providing an explanation for the high degree of conservation.
In addition, the negative charged residues immediately following the
LxCxE motif also interacted with positively charged residues
surrounding the LxCxE binding cleft. It was eventually shown that
both the E2F residues that contact Rb as well as CR1 of E1A bound to
the highly conserved residues located between domains A and B (Lee
et al., 2002; Liu and Marmorstein, 2007; Xiao et al., 2003). Conversely,
it was shown that E2F contacts Rb both the marked box domain as
well as the C-terminal domain that competes directly with CR1 of E1A.
As noted above, the marked box E2F was ﬁrst noted for its importance
in binding to the E4 ORF6/7 19 kDa protein. In this model, E1A uses the
LxCxEmotif of CR2 for high afﬁnity binding to the Rb cleft on domain B
and residues within CR1 to compete with the C-terminal domain of
E2F for binding to the cleft between domain A and B.
While E1A and LT use the LxCxE to bind to Rb, they employ a
different activity to displace E2F from Rb and the Rb-like proteins. It
was recognized that the N-terminal 100 residues of LT has a J domain
found in the large family of DnaJ/Hsp40 molecular chaperones
(Campbell et al., 1997; Sheng et al., 1997; Srinivasan et al., 1997;
Stubdal et al., 1997). The J domain serves to recruit Hsc70 and
activate its ATPase activity to promote chaperone activity. The J
domain of LT cooperates with the LxCxE motif to dissociate p130 and
p107 from E2F4 in an ATP-dependent manner (Sullivan et al., 2000;
Zalvide et al., 1998). A crystal structure of LT with Rb demonstrated
that certain residues within the J domain of LT made direct contacts
with Rb and cooperated with the LxCxE motif (Kim et al., 2001).
Although a CR1 motif had been proposed for LT based on homology
with E1A, these residues did not appear to participate in LT binding
to Rb (Dyson et al., 1989b).
LT inactivates the p107 and p130 tumor suppressor functions
The small DNA tumor viruses have been useful to detect the
growth suppressive functions of Rb as well as p107 and p130. A
number of features distinguish p107 and p130 from Rb. There is a
higher degree of homology between p107 and p130 compared to Rb.
In addition, the primary sequences of mammalian p107 and p130
appear more similar to the Rb homologues in ﬂy and worm (Du et al.,
1996; Lu and Horvitz, 1998; van den Heuvel and Dyson, 2008). Cyclins
A and E and Cdk2 and Cdc2 bind speciﬁcally to p107 and p130 in a
central domain that separates the pocket domains A and B. In addition,p130 and p107 and not Rb form the DREAM (DP, E2F, RB-like, and
MuvB) complex that is similar to complexes observed in ﬂy and worm
(Harrison et al., 2006; Korenjak et al., 2004; Lewis et al., 2004;
Litovchick et al., 2007; Osterloh et al., 2007). While Rb binds to the
activating E2F molecules (E2F1, E2F2 and E2F3), p107 and p130 bind
preferentially to the repressor E2F4 and E2F5.
The Rb1 knockout mouse strain has severe defects in the
hematopoietic and neural development while Rbl1 and Rbl2 knock-
outs have a milder phenotype. To distinguish the role of LT in
inactivating Rb and the Rb-like proteins various mutants of LT were
expressed in ﬁbroblasts derived from Rb1-null embryos. Although
wild type LT could transform Rb1-null MEFs, mutants in the LxCxE
motif were transformation defective implying that there were
additional cellular targets of the LxCxE motif (Christensen and
Imperiale, 1995; Zalvide and DeCaprio, 1995). It was recognized that
the SV40 LT reduced the phosphorylation status of p130 and p107 and
that this was dependent on the LxCxE and J domains (Lin and
DeCaprio, 2003; Stubdal et al., 1996). Given the apparent speciﬁcity of
the J domain effect on the phosphorylation state of p107 and p130, the
ability of J domain LT mutants were tested in MEFs derived from Rbl1-
null and Rbl2-null mice. While the LxCxE motif was required to
transform all MEFs, the J domain was not required in the Rbl1;Rbl2
double knockout MEFs (Stubdal et al., 1997; Zalvide et al., 1998). These
and other results suggest that the J domain of LT is required to
speciﬁcally inactivate the growth suppressive functions of p107 and
p130 and displace them from E2F4 (Sullivan et al., 2004).
Do E1A and LT promote gain-of function in Rb?
The model that Rb function is inactivated by binding to E1A, LT and
E7 has served to bring deep insight into how Rb functions to repress
transcription of a variety of genes involved in cell cycle progression
and development. The basic model assumes that when LT or E1A
binds, Rb is released from E2F on promoters thereby allowing gene
expression. However, this model greatly simpliﬁes the complexity
involved in the large number of potential interactions with Rb, p107
and p130 and the extended family of E2F and DP molecules.
In addition, recent reports suggest that this model may be an
oversimpliﬁcation (Fig. 1).
Ghosh and Harter generated 3T3 cells that expressed an inducible
form of E1A and determined that E1A could bind to cellular promoters
in a chromatin immunoprecipitation (ChIP) assay (Ghosh and Harter,
2003). Importantly, E1A could bind to E2F promoters that were bound
to p130 and E2F4. They observed that there was signiﬁcant change in
histone modiﬁcation with a decrease in Histone 3-lysine 9 (H3K9)
methylation and an increase in H3K9 acetylation correlating with an
increase in gene expression. They proposed that E1A served to bind to
a p130/E2F4-bound promoter to directly modify the chromatin
structure to promote gene expression.
These observations were extended by two reports from the Berk
and Kurdistani labs that examined the fate of chromatin in primary
human ﬁbroblasts after being infected with Adenovirus expressing
the small 12S E1A gene. In the ﬁrst report, it was shown that E1A
induces a signiﬁcant decrease in the amount of acetylation on H3K18
and that this effect was dependent on E1A binding to p300 and CBP
(Horwitz et al., 2008). In the second report, ChIP was performed on
chromatin prepared at intervals after Adenovirus infection and probed
on a genome scale using a microarray with tiled probes for 17,000
promoters (ChIP-chip) (Ferrari et al., 2008). Not only did E1A bound to
thousands of promoters but also it did so with a great variety when it
became associated after infection and for how long it remained.
They identiﬁed three classes of genes using unbiased clustering
and found that classes could be described as antiviral, cell cycle and
differentiation related genes. Remarkably, E1A association with the
promoters of antiviral and cell cycle related began within 2 h after
infection and was nearly absent at 24 h. In contrast, E1a binding to the
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Enrichment for H3K18ac was coincident with E1A association on the
antiviral and cell cycle promoters and consistent with recruitment of
p300 and CBP to these promoters in an E1A-depndent manner. In
contrast, enrichment for H3K18ac, p300 and CBP was not observed on
the differentiation related gene promoters. Therefore it appeared that
E1A was serving two functions, depleting Rb and p107 from E2F-
dependent cell cycle promoters and recruiting the Rb factors to the
differentiation-related promoters to repress their gene expression. It
is possible that E1A recruits p300/CBP to Rb/p107 bound cell cycle
promoters to induce acetylation of H3K18ac and promote cell cycle
progression. Conversely, E1A may bind to p300/CBP dependent anti-
viral and differentiation promoters and recruit Rb/p107 to repress
these promoters. In this model, E1A binding to the Rb and p300/CBP
factors serves multiple roles. In a similar manner, it is conceivable that
E1A binding to p400, TRRAP and other chromatin modiﬁers on
promoters may serve to selectively activate or repress gene expression
by recruiting p300/CBP or Rb/p107 complexes.
Conclusions
The study of the interaction between the viral oncoproteins E1A, LT
and E7 and Rb has provided important insights into tumor suppres-
sion, cell cycle control, and gene expression. These viral proteins have
probed the structure and function of Rb and the Rb-related proteins in
many ways. It is reasonable to assume that the continued study of
these transforming viruses will bring additional insights to our
understanding of Rb's role in tumorigenesis.
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